Literature DB >> 8680897

Drug resistance in cytomegalovirus: current knowledge and implications for patient management.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8680897

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN： 1077-9450


× No keyword cloud information.
  7 in total

1.  Evaluating phenotype and genotype of drug-resistant strains in herpesviruses.

Authors:  G Andrei; P Fiten; E De Clercq; R Snoeck; G Opdenakker
Journal:  Mol Biotechnol       Date:  2001-06       Impact factor: 2.695

2.  Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance. Adult AIDS Clinical Trials Group CMV Laboratories.

Authors:  S Chou; N S Lurain; A Weinberg; G Y Cai; P L Sharma; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

Review 3.  Resistance of human cytomegalovirus to antiviral drugs.

Authors:  A Erice
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling.

Authors:  R A Johnson; X Wang; X L Ma; S M Huong; E S Huang
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates.

Authors:  J J McSharry; N S Lurain; G L Drusano; A L Landay; M Notka; M R O'Gorman; A Weinberg; H M Shapiro; P S Reichelderfer; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates.

Authors:  J M McSharry; N S Lurain; G L Drusano; A Landay; J Manischewitz; M Nokta; M O'Gorman; H M Shapiro; A Weinberg; P Reichelderfer; C Crumpacker
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

Review 7.  What clinicians need to know about antiviral drugs and viral resistance.

Authors:  R L Hodinka
Journal:  Infect Dis Clin North Am       Date:  1997-12       Impact factor: 5.982
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.